Keel Point, LLC Nkarta, Inc. Transaction History
Keel Point, LLC
- $1.28 Billion
- Q1 2025
A detailed history of Keel Point, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Keel Point, LLC holds 26,403 shares of NKTX stock, worth $46,469. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,403Holding current value
$46,469% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NKTX
# of Institutions
118Shares Held
61MCall Options Held
13.7KPut Options Held
10.3K-
Ra Capital Management, L.P. Boston, MA10.8MShares$19 Million0.41% of portfolio
-
Tang Capital Management LLC San Diego, CA7.06MShares$12.4 Million0.84% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$7.14 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$6.63 Million3.2% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$6.28 Million0.62% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $85.6M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...